- About
- Events
- Resource Center
Archives
Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
In this live event, Joe Cirrincione, PharmD, MBA and Katherine Sulkowski, PharmD, discuss the high prevalence of major depressive disorder (MDD) among patients with chronic kidney disease (CKD).
Major depressive disorder affects more than 260 million people worldwide1. The reported prevalence of depression in patients with chronic kidney disease ranges from 20-65%2. This webinar provides an overview of both MDD and CKD and discusses their overlap of symptomology.
1World Health Organization. Fact Sheet on Depression. (2012) https://www.who.int/health-topics/depression#tab=tab_1
2Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202.Drs Cirrincione, Sulkowski, and Voigt are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).
Featured Speakers
Joe Cirrincione
-
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Joe Cirrincione, PharmD, MBA is a Senior Managed Market Liaison at Otsuka, based out of Pittsburgh, Pennsylvania. Dr Cirrincione earned his Doctor of Pharmacy and Master of Business Administration from Duquesne University. Prior to joining Otsuka, Dr Cirrincione held a position at Highmark Blue Cross Blue Shield as a Pharmacy Sales Consultant, working with employer groups on their pharmacy benefits and plan design, and he has experience working for chain and independent community pharmacies.
Katie Sulkowski, PharmD
Clinical & Scientific Liaison-
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Katie is a Clinical & Scientific Liaison with Otsuka who covers the Western Pennsylvania territory as well as two cities in West Virginia. Katie received her doctorate of pharmacy from Duquesne University in 2015. Prior to working withOtsuka, Katie was a clinical pharmacy specialist at UPMC Health Plan and adjunct faculty at Duquesne University where she taught the Managed Care Principles & Policies course to graduate-level students.
Lisa Voigt, PharmD, BCPS, BCCCP
Nephrology Senior Medical Science Liaison-
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Lisa Voigt, PharmD, BCPS, BCCCP is a PharmD who works as a Medical Science Liaison in Nephrology with Otsuka Pharmaceutical Development & Commercialization, Inc. Prior to joining Otsuka in 2019, Dr Voigt practiced as a Medical Intensive Care Unit and Surgical Intensive Care Unit Pharmacist for 15 years at a tertiary medical center in Buffalo, New York. She earned her Bachelor of Science degree in Pharmaceutics and PharmD from the SUNY Buffalo School of Pharmacy and Pharmaceutical Sciences. She completed a Post-Graduate year 1 Pharmacy Residency and Post-Graduate year 2 Critical Care/Emergency Medicine Pharmacy Residency at the University of Rochester Medical Center in Rochester, New York. Dr Voigt is a Past-President of the New York State Council of Health-system Pharmacists and has served on the Board of Directors for the past 10 years. She is also Past-President of the Western New York Society of Health-system Pharmacists. She is an Adjunct Assistant Professor at SUNY Buffalo, School of Pharmacy and Pharmaceutical Sciences. Dr Voigt holds board certifications in pharmacotherapy as well as critical care pharmacotherapy.
Location
Capital Grille
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2023 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - Events
